# Ipsen Bioscience, Inc. – FDA Inspection, Dec 5, 2017

Source: https://www.keypedia.com/records/fda_inspections/ipsen-bioscience-inc/a3162201-ae4c-49f9-b2ed-0aae5a9160e7
Source feed: FDA_Inspections

> FDA inspection 1034205 of Ipsen Bioscience, Inc., December 05, 2017. Classification: Official Action Indicated (OAI). 4 citations under 21 CFR part 211. Form 483 issued. 3 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1034205
- Company Name: Ipsen Bioscience, Inc.
- Inspection Date: 2017-12-05
- Classification: Official Action Indicated (OAI)
- Classification Code: OAI
- Project Area: Generic Drug Evaluation
- Product Type: Human Drugs
- Center: Human Drugs
- Office Name: New England District Office
- Citation Count: 4

## Related Documents

- FDA Inspection 1270829 - 2025-05-20
- [FDA Inspection 1080531 - 2019-02-26](https://www.keypedia.com/records/fda_inspections/ipsen-bioscience-inc/4f32d07c-8374-4664-8b27-d5f32643083a)
- FDA Inspection 940914 - 2015-07-17

## Related Officers

- Issuing Officer
- [Robert J. Martin](https://www.keypedia.com/people/robert-j-martin/8bd5c75a-ec53-4ae5-9739-a39489686cae)

Company: https://www.keypedia.com/companies/ipsen-bioscience-inc/657abb7a-6718-44e6-b6d5-aa7f903387d8

Office: https://www.keypedia.com/offices/new-england-district-office/aa458072-2f1d-4231-89f5-21ba7a3b7144